// App-Quantinova.ai

EP499 : SUBCUTANEOUS EPCORITAMAB IN PATIENTS WITH RELAPSED/REFRACTORY B-CELL NON-HODGKIN LYMPHOMA: SAFETY PROFILE AND ANTI-TUMOR ACTIVITY

Researchers

Presenter

  • Rogier Mous

Principal Investigators

  • Pieternella Lugtenburg

  • Martin Hutchings

  • Peter Johnson

  • Kim Linton

  • David John Lewis

  • Martine Chamuleau

  • Anna Sureda Balari

  • David Cunningham

  • Brian Elliott

  • Dena DeMarco

  • Kuo-mei Chen

  • Michael Roost Clausen

Medical Centers

  • Cancer Research UK Centre, Cancer Sciences Division, University of Southampton, Southampton, United Kingdom

  • NSGO & Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark

  • On behalf of the Lunenburg Lymphoma Phase I/II Consortium-HOVON/LLPC, VU University Medical Center,Amsterdam,Netherlands

  • Instituto Catalan de Oncologia, Hospital Duran i Reynals, Hospitalet de Llobregat, Barcelona, Spain

  • The Royal Marsden Hospital NHS Foundation Trust, London & Surrey, United Kingdom

  • Genmab,Princeton, NJ,United States

  • On behalf of the Lunenburg Lymphoma Phase I/II Consortium-HOVON/LLPC, Erasmus MC Cancer Institute, Department of Hematology,Rotterdam,Netherlands

  • on behalf of the Lunenburg Lymphoma Phase I/II Consortium-HOVON/LLPC, Universitair Medisch Centrum Utrecht, Utrecht, Netherlands

  • Plymouth University Medical School, Plymouth, United Kingdom

  • Vejle Hospital, Vejle, Denmark

  • Manchester Cancer Research Centre, Manchester, United Kingdom

Locations

  • United Kingdom

  • Denmark

  • Netherlands

  • Spain

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Autoimmune (AI)

  • Blood/haematological Diseases

Disease

  • B-Cell Non-Hodgkin Lymphoma

  • Cytokine release syndrome

  • Non-Hodgkin's Lymphoma

  • Non‐Hodgkin Lymphoma

  • Hodgkin's Lymphoma

  • Lymphomas

Biomarkers

  • Cytokeratin 20

  • Twist-related protein 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • I/II

Study Id's

  • NCT03625037

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved